Both in Biotechnology
Kalaris Therapeutics vs Champions Oncology
Over the past year KLRS returned −54.3% and CSBR returned −24.9%; their daily moves had a correlation of 0.10.
KLRS −54.3% CSBR −24.9%Growth of $1, one year, split-adjusted
| Metric | KLRS | CSBR |
|---|---|---|
| Price | $2.90 | $4.79 |
| Market cap | $69.0M | $66.7M |
| Today | +1.93% | −2.84% |
| 1 month | −28.0% | −2.8% |
| 6 months | −45.3% | −18.0% |
| Year to date | −65.6% | −30.7% |
| 1 year | −48.3% | — |
| Revenue growth (YoY) | — | +8.8% |
| Gross margin | — | 50.5% |
| Net margin | — | −2.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.1× |
| Net cash | $93.5M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 58.9% | 44.8% |
| Short % of float | 5.7% | 1.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).